{
    "2018-04-23": [
        [
            {
                "time": "2018-04-23",
                "original_text": "Is a Beat in Store for Alexion (ALXN) This Earnings Season?",
                "features": {
                    "keywords": [
                        "Beat",
                        "Earnings",
                        "Alexion"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "What Lies Ahead for Vice ETFs?",
                "features": {
                    "keywords": [
                        "Vice",
                        "ETFs"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "financial products"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-01",
                "original_text": "Johnson & Johnsonâ€™s Revenues Continued to Rise in 1Q18",
                "features": {
                    "keywords": [
                        "Revenues",
                        "Rise",
                        "Johnson & Johnson",
                        "1Q18"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-25",
                "original_text": "Amid drug price worries, earnings to test U.S. pharma, biotech shares",
                "features": {
                    "keywords": [
                        "drug price",
                        "earnings",
                        "pharma",
                        "biotech"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-26",
                "original_text": "Q1 Earnings Surprise Well in Cards: Healthcare ETFs to Buy",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Surprise",
                        "Healthcare",
                        "ETFs"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-27",
                "original_text": "Is a Beat in Store for Bristol-Myers (BMY) in Q1 Earnings?",
                "features": {
                    "keywords": [
                        "Beat",
                        "Earnings",
                        "Bristol-Myers"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-30",
                "original_text": "Will Global Industrial Unit Boost Ecolab's (ECL) Q1 Earnings?",
                "features": {
                    "keywords": [
                        "Global",
                        "Industrial",
                        "Unit",
                        "Boost",
                        "Ecolab",
                        "Earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "industrial goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-02",
                "original_text": "5 Dividend Growth Stocks With Upside To Analyst Targets",
                "features": {
                    "keywords": [
                        "Dividend",
                        "Growth",
                        "Stocks",
                        "Analyst",
                        "Targets"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-03",
                "original_text": "Implied DIVB Analyst Target Price: $29",
                "features": {
                    "keywords": [
                        "DIVB",
                        "Analyst",
                        "Target",
                        "Price"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "financial products"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}